Coati Allergy: The Procyonid Data Void and What Raccoon Evidence Tells Us
Coati allergy involves potential IgE sensitization to proteins from coatis (Nasua nasua), ring-tailed procyonids from Central and South America kept as exotic pets in some US states. No published allergy case reports or allergen characterization studies exist for coatis. Risk is inferred from the single raccoon allergy case (Stöger 1994) and from Savolainen et al. 1997 RAST inhibition data showing albumin cross-reactivity among procyonids, ferrets, foxes, and dogs. Management combines exposure avoidance with standard allergic rhinitis pharmacotherapy.
Free · 5 min · Insurance accepted
Key facts
Zero published allergy case reports or allergen characterization studies exist for coatis (Nasua spp.) — allergenicity is inferred entirely from procyonid family relationships.
WHO/IUIS Allergen Nomenclature Sub-Committee, allergen.org, 2024
The only published procyonid allergy case (Stöger et al., 1994) documented rhinoconjunctivitis, angioedema, and asthma from pet raccoon exposure with positive skin prick test and RAST.
RAST inhibition studies demonstrated shared serum albumin epitopes across ferret, fox, mink, raccoon, and dog, placing coatis in a broad mammalian cross-reactive albumin network.
No scientific basis supports claims for hypoallergenic status in any furred pet species — coatis produce dander, urine proteins, and saliva allergens through the same mammalian pathways as cats and dogs.
What Is Coati Allergy — The Procyonid Family Without Data
Coati allergy refers to potential IgE-mediated hypersensitivity reactions to proteins shed by coatis (*Nasua nasua*), also called coatimundis — social, ring-tailed procyonid mammals native to Central and South America.
Coatis are members of the Procyonidae family, which places them in the same family as raccoons (*Procyon lotor*), kinkajous (*Potos flavus*), and ring-tailed cats (*Bassariscus astutus*).
The honest opening for this page: no published allergy case reports exist for coatis. Zero. No allergen characterization studies have been performed, no WHO/IUIS allergen names exist for any Nasua species, and no commercial IgE tests are available. This is a genuine research void — not a finding that coatis are non-allergenic.
What we can say with confidence is that coatis are mammals that shed dander, produce urine proteins, and secrete saliva — the three universal allergen sources shared by all mammals. The Procyonidae family relationship provides the best available indirect evidence for allergic risk: the only procyonid with a published case is the raccoon. Stöger et al. (Allergy, 1994) documented rhinoconjunctivitis, angioedema, and asthma from pet raccoon exposure with positive skin prick testing and RAST — confirming that procyonid dander can cause genuine IgE-mediated allergy. Coatis, as procyonid relatives, likely share allergen protein families with raccoons.
Additionally, RAST inhibition studies by Savolainen et al. (1997) demonstrated shared albumin epitopes among ferret, fox, mink, raccoon, and dog serum albumins — placing the entire procyonid group in a broader cross-reactive albumin network that likely includes coatis.
For the raccoon reference case, see the raccoons page. For the arboreal procyonid sister page, see the kinkajous page.
Potential Symptoms of Coati Allergy
Recognizing symptoms early helps you get the right treatment faster.
Allergic rhinitis
mildSneezing, nasal congestion, and rhinorrhea developing in household or zoo settings where coatis are present; expected first symptom if sensitization occurs.
Allergic conjunctivitis
mildItchy, watery, red eyes accompanying nasal symptoms during coati handling or time spent in rooms where coatis are housed.
Contact urticaria
moderateHives at skin contact sites — hands, forearms — from coati saliva, urine, or dander during direct handling; particularly possible at bite sites.
Asthma (by procyonid analogy)
moderateLower airway bronchospasm from sustained coati allergen exposure; plausible by analogy with the raccoon case (Stöger 1994), which included asthma as a documented complication.
Angioedema
severeDeep skin swelling beyond the superficial urticaria layer; documented in the Stöger 1994 raccoon case and plausible for related procyonid exposure in sensitized individuals.
When to see a doctor
Coati allergy symptoms, if they occur, would be expected to follow the standard mammalian pet allergy pattern: allergic rhinitis and conjunctivitis from inhalation of aerosolized dander and urine proteins, contact urticaria from direct handling, and potentially lower airway involvement with sustained intensive exposure. The raccoon precedent (Stöger 1994) is the closest clinical reference: the raccoon-allergic patient experienced rhinoconjunctivitis, angioedema, and asthma — indicating that procyonid allergens can trigger a full spectrum of IgE-mediated reactions up to and including asthmatic severity. Coati owners who develop similar symptoms should consider coati allergen as a possible cause. Bite injuries add a specific risk: coati saliva delivered through skin puncture wounds may trigger localized urticaria at the bite site in sensitized individuals, similar to what is documented from other exotic animal bites. If a coati bite produces hives, swelling, or systemic symptoms beyond normal wound response, allergist evaluation is warranted. Seeking emergency care: call 911 immediately if you experience throat swelling, difficulty breathing, widespread hives spreading beyond the bite or contact zone, dizziness, or faintness after coati contact. These signs may indicate anaphylaxis requiring epinephrine.
Coati Allergy and Asthma Risk — Raccoon Evidence by Analogy
No coati-specific asthma case has been published. However, the raccoon case (Stöger et al., Allergy, 1994) documented asthma as part of the clinical presentation — alongside rhinoconjunctivitis and angioedema — from pet raccoon (a Procyonidae family member) exposure. If raccoon procyonid proteins can trigger asthma, it is biologically plausible that coati procyonid proteins could as well, especially in atopic individuals with existing respiratory sensitization. Coati owners who develop persistent cough or wheeze that correlates with time spent near their animal should not dismiss it as unrelated. The novel occupational and exotic pet allergen principle is important: absence of a published case does not mean absence of risk. Any respiratory symptom developing after acquiring a coati warrants evaluation by a board-certified allergist.
Complications of Coati Allergy
The primary complication of unrecognized coati allergy is progressive sensitization that develops unchecked while the owner attributes symptoms to other causes (dust, mold, seasonal pollen) — delaying appropriate management and allowing more severe allergic disease to develop. Zoonotic disease risks from coatis — including rabies, Baylisascaris roundworm, and leptospirosis — are concurrent concerns that are clinically distinct from IgE-mediated allergy but share the same exposure source. A coati bite that causes localized urticaria in a sensitized individual simultaneously creates a wound infection risk requiring tetanus prophylaxis consideration and rabies risk assessment if vaccination status is unknown. For households with children, the allergen accumulation pattern of an active, free-roaming coati — spreading dander on floors, furniture, and children's play areas — creates an elevated sensitization risk for young family members with atopic predisposition.
Progressive allergic rhinitis advancing to asthma
Untreated rhinitis from coati allergen exposure may progress to occupational or household asthma over months to years of continued unprotected contact.
Concurrent zoonotic bite wound complications
Coati bites that trigger urticaria in sensitized individuals simultaneously create infection risk; wound care, tetanus, and rabies risk assessment must accompany allergy evaluation.
Family member sensitization
Active coatis roaming freely in household spaces deposit dander in all areas; children and other household members with atopic predisposition may develop sensitization even without direct animal contact.
What Could Cause Coati Allergy and Who Is at Risk?
Coati allergy, if it develops, would arise through IgE sensitization to dander, urine proteins, and saliva shed by coatis during handling or in shared living spaces. The exposure context is primarily exotic pet ownership — coatis are legal to own with permits in a number of US states including Texas and Florida, and they appear in the exotic pet trade as young animals that are hand-raised from infancy to reduce their natural aggressiveness.
Ring-tailed coati (South American coati)
Nasua nasua
White-nosed coati (Central American coati)
Nasua narica
Western mountain coati
Nasuella olivacea
Raccoon (Procyonidae family reference species — Stöger 1994 case)
Procyon lotor
How it works
Coati allergy, if present, would operate through Type I IgE-mediated hypersensitivity: allergen proteins from coati dander or urine sensitize the immune system via IgE antibody production, binding to mast cell FcεRI receptors. Re-exposure triggers degranulation and histamine release producing rhinitis, urticaria, or bronchospasm. The cross-reactive albumin network documented by Savolainen et al. 1997 suggests that coati serum albumin (approximately 67 kDa) may share IgE-binding epitopes with raccoon, ferret, dog, and fox albumins — meaning existing sensitization to any of those species could accelerate coati sensitization through primed IgE. No coati-specific allergen proteins have been characterized.
Coatis are active, social, and mischievous animals. Unlike cats or dogs that spend hours resting, coatis explore their environment continuously, spreading dander onto surfaces throughout their living space. Their strong, mobile snout is used to probe into every available crevice, and their urine marking behavior deposits proteins throughout their territory. Zoo keepers caring for coati colonies and wildlife sanctuary workers caring for injured or confiscated coatis represent a secondary occupational exposure group.
The indirect evidence for coati allergenicity comes from the procyonid family connection. Raccoons (the only studied procyonid) produced clear IgE-mediated disease in the Stöger 1994 case. The Savolainen 1997 cross-reactivity data places coati albumins in the same broad pan-mammalian albumin cross-reactivity network that includes ferret, dog, fox, mink, and raccoon. Pre-existing sensitization to dogs, cats, or ferrets through these shared albumin epitopes may prime the immune system to sensitize more rapidly to coati proteins.
Bite injuries from coatis are a practical concern: coatis have strong jaws and canine teeth, and bites from even hand-raised animals are common. A bite delivers saliva proteins — potential allergens — directly through broken skin, potentially accelerating sensitization.
Risk factors to watch for
Exotic pet coati ownership
Legal in some US states under exotic pet permits; household owners who provide daily feeding, handling, and cleaning have the most sustained direct contact and highest sensitization risk.
Pre-existing raccoon, ferret, or dog allergy
The Savolainen 1997 albumin cross-reactivity network links coati albumin to raccoon, ferret, dog, fox, and mink; existing sensitization to any of these species may accelerate coati sensitization.
Zoo and sanctuary work with coatis
Wildlife facilities caring for wild-born or confiscated coatis have occupational exposure through cleaning, feeding, and veterinary procedures.
Coati bites during handling
Coati bites are common — their pointed carnivore dentition and exploratory behavior make bites likely in household or wildlife management contexts. Saliva protein delivery through bite wounds accelerates dermal sensitization.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Coati Allergy Without a Standardized Test
Diagnosing coati allergy follows the same approach used for all data-void exotic animal allergies: detailed allergen exposure history, work-relatedness assessment if occupational, and clinical correlation rather than laboratory confirmation. No commercial coati IgE test, ImmunoCAP assay, or standardized skin test extract exists. The most diagnostically useful step is establishing temporal correlation: did symptoms begin or worsen after acquiring the coati? Do they improve when the animal is temporarily housed elsewhere (a friend's home or a veterinary boarding facility)? Do they return when the animal comes back? This challenge-withdrawal-rechallenge pattern provides strong circumstantial evidence of coati allergen sensitization. For physicians considering formal testing, cross-reactive testing with raccoon extract (where available at research centers) or commercial dog or ferret ImmunoCAP (reflecting the Savolainen 1997 albumin cross-reactivity network) may provide partial sensitization evidence — but a positive dog test does not confirm coati sensitization, only shared albumin sensitization. At-home allergy testing services such as Curex provide panels covering 40+ common allergens including dogs and cats, which help characterize baseline IgE sensitization and identify whether existing dog sensitization through albumin cross-reactivity is part of the clinical picture. These results inform the allergist's overall management planning. A board-certified allergist should guide the diagnostic process; the exotic animal context warrants specialist expertise rather than a community practice approach.
Temporal allergen challenge-withdrawal assessment
Clinical assessment of whether symptoms correlate with coati presence and improve with animal temporary removal; the most reliable available diagnostic method for coati allergy.
Cross-reactive IgE testing via dog or raccoon extract
Commercial dog (Can f family) or raccoon IgE testing may identify shared albumin sensitization through the Savolainen 1997 cross-reactive network, providing partial evidence of procyonid sensitization.
Ferret-specific IgE (ImmunoCAP e217)
Ferret IgE testing is commercially available and ferret shares albumin epitopes with raccoon and predicted coati; a positive result may support procyonid cross-reactive sensitization.
Skin prick testing with non-standardized coati extract
Available only at specialized academic allergy centers if extract can be prepared from coati hair or urine; not commercially available.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
Coati-specific allergen immunotherapy does not exist. No coati allergen protein has been characterized, and the research investment required to develop a standardized coati extract for SCIT or SLIT would not be commercially justified given the small exposed population. However, a partial immunotherapy strategy may be relevant through the procyonid cross-reactivity network. For coati owners who are co-sensitized to dogs — which is common, given the broad albumin cross-reactivity between dog, raccoon, and predicted coati albumins documented by Savolainen et al. 1997 — dog allergen immunotherapy might reduce the overall albumin IgE burden that contributes to coati reactions through shared epitopes. This is inference rather than established clinical practice, but it represents a biologically plausible mechanism. For coati owners who also have common respiratory allergen sensitizations (dust mites, cat dander, pollens, molds), immunotherapy targeting those well-characterized allergens reduces baseline allergic inflammation and may raise the symptom threshold for coati-related triggers. Sublingual immunotherapy drops for common allergens, offered by providers like Curex starting at $39/month, provide an accessible at-home option for this component of allergic burden management. A board-certified allergist familiar with exotic pet allergy should guide any immunotherapy decision — including the question of whether addressing dog sensitization might have meaningful cross-reactive benefit for coati symptoms.
Temporal exposure assessment
Document symptom correlation with coati presence versus absence — ideally through a brief period of animal temporary relocation — to confirm the allergic exposure source.
Comprehensive IgE testing for co-allergens
Standard IgE testing including dog, cat, ferret, dust mites, and molds characterizes the full sensitization profile and identifies cross-reactive procyonid pathways.
Co-allergen SLIT for identified sensitizations
If dust mites, cat, or common pollens are identified as co-sensitizations, sublingual immunotherapy for those targets reduces baseline inflammatory burden.
HEPA allergen reduction in parallel
Environmental controls — HEPA filtration, bedroom exclusion zone, hard flooring — reduce ongoing allergen dose while immunotherapy addresses underlying sensitization for co-allergens.
“No coati-specific immunotherapy trials; co-allergen SLIT shows 60–80% improvement for targeted common allergens”
Treat your Coati allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living with a Coati and Managing Allergy
Coati owners who develop allergy symptoms face the same difficult calculus as owners of any pet that proves allergenic: the emotional bond with the animal on one side, and the health consequences of continued exposure on the other. This is not a decision a web page can make — but providing honest information helps owners make it thoughtfully. The first step is confirmation that the coati is actually the allergen source. Temporary re-homing of the coati for two to four weeks while systematically cleaning the household allergen reservoir (washing all soft furnishings, vacuuming with HEPA, running air purifiers) can establish whether symptoms substantially improve. If they do, and if they return when the coati returns, the diagnosis is reasonably confirmed. For owners who want to keep their coati while managing allergy: strict bedroom exclusion, daily HEPA filtration, regular household cleaning, and pharmacological management can reduce but typically not eliminate exposure. Allergy symptoms in this setting are a chronic management challenge rather than a curable condition — sustained pharmacotherapy, regular allergist follow-up, and honest self-assessment of whether the arrangement is sustainable are the ongoing tasks.
The temporary re-homing test
Before making permanent decisions about the animal, arrange a 2–4 week period of coati temporary re-homing combined with thorough household cleaning — this is the most direct way to determine whether your symptoms are coati-related.
Bedroom as an allergen-free zone
Maintaining the bedroom as a strictly coati-free zone is the single highest-value environmental modification — it provides 6–8 hours of daily allergen-free recovery time and meaningfully reduces total exposure even when the animal is in other rooms.
Document symptoms for your allergist
A symptom diary that records severity alongside coati contact intensity gives your allergist the data needed to make evidence-based treatment adjustments and to advise on long-term management sustainability.
Seasonal Patterns
January - December
medium intensity
Prevention Tips
Pre-acquisition allergist consultation
If you have existing dog, cat, or ferret allergy, consult an allergist before getting a coati — the Savolainen 1997 cross-reactive albumin network means your existing sensitization may accelerate coati allergy development.
Bedroom exclusion zone from day one
Establishing a coati-free bedroom zone before symptoms develop — not after — prevents the heaviest allergen loading in the environment where you spend the most hours.
Wash hands after all coati contact
Saliva, urine, and dander on hands become facial and mucous membrane allergen sources when you touch your face or eyes; hand washing after every handling session reduces this route.
HEPA air purifier in living areas
Install HEPA filtration in rooms where the coati is most active before symptoms develop — proactive air quality management prevents high allergen accumulation.
Hard flooring in coati areas
Carpets and upholstered furniture trap dander; hard flooring in the coati's primary range area reduces allergen reservoir buildup compared to carpeted environments.
Prognosis for Coati Allergy
Prognosis for coati allergy can only be extrapolated from the broader mammalian pet allergen literature. For individuals who implement the standard environmental management interventions and maintain pharmacological treatment, stable symptom control is achievable in many cases — particularly where exposure intensity is moderated by household environmental controls. For highly sensitized individuals or those with pre-existing asthma, coati ownership may prove clinically incompatible with respiratory health, and re-homing the animal may become the medically necessary recommendation despite the emotional difficulty. This is more likely in atopic individuals who were already sensitized to raccoon, ferret, or dog before acquiring the coati — the cross-reactive albumin priming in those cases may produce more rapid and severe sensitization. Early identification of coati-related symptoms and prompt institution of management measures (environmental controls, pharmacotherapy, allergist consultation) offers the best long-term outcome. Continuing without any management intervention until severe disease develops is the trajectory most likely to result in the worst outcome.
Key takeaways
No published allergy case reports exist for coatis; risk is inferred from the raccoon Stöger 1994 case and the Savolainen 1997 cross-reactive albumin network across procyonids
Coatis produce dander, urine proteins, and saliva allergens through standard mammalian pathways; absence of case reports does not indicate non-allergenicity
Pre-existing dog or ferret sensitization via albumin cross-reactivity may accelerate coati sensitization in susceptible individuals
No coati-specific immunotherapy exists; co-allergen SLIT for identifiable sensitizations and environmental management are the primary tools
Coati allergy sits in a diagnostic vacuum — there are no characterized allergens, no validated tests, and no published cases. What we have instead is biological plausibility grounded in procyonid family relationships and the cross-reactive albumin network.
Frequently Asked Questions
Yes, theoretically — coatis are mammals that produce dander, urine proteins, and saliva allergens through the same biological pathways as cats, dogs, and raccoons. No published allergy case reports exist specifically for coatis, but the raccoon case (Stöger et al., Allergy, 1994) confirmed that procyonid family members can cause genuine IgE-mediated rhinitis, angioedema, and asthma. The Savolainen et al. 1997 RAST inhibition data also shows shared albumin epitopes across the procyonid family (raccoon), ferrets, foxes, and dogs — predicting that coati allergens likely cross-react within this network. Absence of case reports reflects the small exposed population, not absence of allergenic potential.
Coatis and raccoons are both members of the Procyonidae family — the raccoon family. Raccoons are the only procyonid species with a published allergy case report: Stöger et al. (Allergy, 1994) documented rhinoconjunctivitis, angioedema, and asthma from pet raccoon exposure, with positive skin prick testing and RAST. Since coatis and raccoons share evolutionary history and protein families (including serum albumin), the raccoon case provides the best available biological analog for predicting coati allergic risk. Coatis are also part of the Savolainen 1997 cross-reactive albumin network linking procyonids with ferrets, dogs, and foxes.
Coati ownership regulations vary significantly by state. As of 2024, coatis are legal to own as exotic pets with permits in some states including Texas, but are restricted or prohibited in others including California, Georgia, and New York. Federal regulations under the Lacey Act restrict interstate transport of wildlife in violation of state laws. Local ordinances may impose additional restrictions. Laws change frequently; prospective owners should verify current regulations with their state wildlife agency before acquiring a coati. Veterinary care availability is also a practical consideration — most general practice veterinarians lack exotic mammal training, and exotic animal specialists are concentrated in urban areas.
Coatis and dogs are not in the same family — coatis are procyonids, dogs are canids. However, the Savolainen et al. (1997) RAST inhibition study demonstrated shared serum albumin epitopes among ferret, fox, mink, raccoon, and dog — a cross-reactive network that likely extends to coatis through their raccoon family relationship. Practically, this means a person with existing dog allergy (sensitization to Can f 3, the dog serum albumin) may have cross-reactive IgE that primes faster sensitization to coati albumin. A positive dog IgE test in a coati owner experiencing symptoms supports procyonid family cross-reactivity as part of the mechanism, but does not confirm coati-specific sensitization.
Coati bites carry two separate concerns: zoonotic disease risk (rabies exposure assessment, tetanus prophylaxis, wound infection) and allergic sensitization. For individuals already sensitized to coati proteins — or to cross-reactive procyonid, ferret, or dog albumins — a bite that delivers saliva allergens directly through broken skin could potentially trigger local urticaria at the bite site, accelerate systemic sensitization, or in highly sensitized individuals theoretically trigger a more systemic reaction. Any bite from a coati should receive standard wound care assessment; individuals who develop hives, swelling beyond the bite site, or systemic symptoms after a coati bite should seek both wound care and allergy evaluation.
No standardized commercial test for coati allergy is available. No ImmunoCAP assay, no standardized skin test extract, and no reference ranges exist for coati-specific IgE. At community allergy practices, the closest available tests would be raccoon or ferret IgE where those extracts are available, or dog IgE through the Savolainen cross-reactive albumin network. A specialized academic allergy center might prepare non-standardized coati hair or urine extract for research-grade skin prick testing. For most patients, the most practically useful diagnostic approach is clinical: temporal symptom correlation with coati presence or absence, combined with a structured allergy history.
True allergic reactions are IgE-mediated — they involve immune sensitization on first exposures and increasingly rapid, reproducible responses on re-exposure, and they can occur with very small allergen amounts in sensitized individuals. Irritant reactions to coati urine involve a non-immune, concentration-dependent mechanism: sufficiently high concentrations of ammonia or other urine components cause physical irritation of the nasal or ocular mucosa without involving IgE. Distinguishing the two matters for management: IgE allergy may progress to asthma and requires allergen avoidance and potentially immunotherapy; irritant reactions are managed primarily by improving ventilation and reducing urine exposure concentration. An allergist can help distinguish the two through clinical history and targeted testing.
No evidence supports coatis as hypoallergenic compared to cats or dogs. 'Hypoallergenic' is an unregulated marketing term with no standardized scientific definition. Coatis produce dander, urine proteins, and saliva allergens like all mammals. Their less common presence as pets means fewer people have been sensitized and fewer case reports exist — but this reflects exposure opportunity, not allergen absence. Hilger et al. (Allergologie Select, 2024) confirmed that no scientific basis for hypoallergenic status exists for any furred pet species. Any individual, regardless of previous pet allergy history, can potentially develop coati sensitization with sufficient sustained exposure.
The closest allergy risk analogs to coatis are other procyonid family members: raccoons (the only one with a published case — Stöger 1994) and kinkajous (also zero published cases — see the kinkajous page). The broader cross-reactive network from Savolainen 1997 also implicates ferrets, foxes, minks, and dogs as species with shared albumin epitopes. For exotic pet owners considering multiple species, each addition to the home expands the total allergen exposure profile and increases cumulative sensitization risk — particularly for individuals already carrying IgE to species in the Savolainen albumin cross-reactivity network.
Medical References
- [1]Stöger P, Wüthrich B, Johansson SG. RAST-specific IgE to common inhalant allergens in patients allergic to pet rodents, guinea pigs, and other small mammals. Allergy. 1994;49(6):472-476.
- [2]Savolainen J, Viander M, Koivikko A. RAST inhibition studies with cross-reactive allergens in pet allergy. Allergy. 1997;52(1):63-70.
- [3]Hilger C, Swiontek K, Hentges F, et al. No scientific evidence supports claims for hypoallergenic furred pets. Allergologie Select. 2024;8:30-42.
- [4]Bush RK. Laboratory animal allergy: an update. ILAR Journal. 2003;44(1):28-51.
- [5]WHO/IUIS Allergen Nomenclature Sub-Committee. Allergen nomenclature database. World Health Organization / International Union of Immunological Societies. Accessed 2024.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Coati allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.